Tag Archives: REFR

Top 5 Stocks To Invest In Right Now

Shares of Johnson & Johnson JNJ, +0.92% inched 0.92% higher to $179.47 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, -0.71% falling 0.71% to 4,448.08 and Dow Jones Industrial Average DJIA, -0.79% falling 0.79% to 35,343.28. This was the stock’s seventh consecutive day of gains. Johnson & Johnson hit a new 52-week high, surpassing its previous peak of $177.89, which the company achieved on August 16th.

The stock demonstrated....More>>>

Top 10 Casino Stocks To Buy For 2023

As some of the few travel stocks that have failed to fully recover from the pandemic, plenty of investors have tried to bottom-fish in cruise-line names like Carnival (NYSE:CCL) stock. Unfortunately, these contrarian wagers have failed to pan out.

Investors who have dabbled in CCL or its peers haven’t reaped substantial gains. Instead, going against the grain has led to heavy losses. Although the industry is in a much better place now compared to last year, cruise lines have a way to go before attaining pre-virus revenue and earnings levels.

Worse yet, this recovery, which....More>>>

Top 10 Low Price Stocks To Buy For 2023

Betting on bargain stocks that have a low price-to-earnings (P/E) ratio is a convenient and common investment approach. The perception is that the lower the P/E, the higher is the value of the stock. This inference is drawn on the simple logic that a stock’s current market price does not justify (is not equivalent to) its higher earnings and therefore has room to run.

Naturally, there are very few investors who pay attention to stocks with an increasing P/E. But this often-overlooked trend can prove useful in finding great stocks. Let’s dig a little deeper.

Why Stocks....More>>>

Top Biotech Stocks To Watch For 2019

Investment bank analysts are convinced these three biotech stocks are worth a lot more than their current market values. All have recently been given price targets that suggest they could double your money, or better.

Here’s why analysts are willing to stick their necks out and predict huge gains ahead for these fledgling drugmakers. Just remember, huge potential rewards usually come with a great deal of risk.

Company (Symbol) Bank Recent Price Target Implied Upside at Recent Prices
Tocagen Inc. (NASDAQ:TOCA) Citigroup $27 141%
Vital Therapies, Inc. (NASDAQ:VTL)....More>>>

Top 10 Medical Stocks To Watch For 2019

The typical business model of an engineering consultancy firm like Exponent, Inc. (NASDAQ:EXPO) is simple yet attractive. These firms are pure manpower-driven businesses that cater to a vast array of industries, work mostly on medium-to-long-term contracts, have negligible direct costs other than manpower, and have strong foreseeability of revenues. Also, the low capital expenditure associated with such businesses makes them very attractive for leveraged buyouts.

EXPO also has all these characteristics and the company has been growing extremely well over the past decade. Our assessment....More>>>